Phase IV (2016-20)

in page functions

In 2014, the Gavi Board approved a new five-year strategy to support our mission 2016–2020

GAVI Alliance replenishment brochure

The Vaccine Alliance’s second replenishment raised over US$ 7.5 billion to finance immunisation programmes in the 2016–2020 period.

In June 2014, the Gavi Board approved a revised five-year strategy to continue to build sustainable programmes and deliver on our mission to save children’s lives and protect people’s health by increasing equitable use of vaccines in lower-income countries.

The 2016-2020 strategy builds on the previous strategy and draws lessons from the past 15 years. It is designed to adapt to the changing environment in which the Vaccine Alliance and the countries we support are operating.


The 2016-20 strategy has four goals, each supporting our overall mission: “to save children’s lives and protect people’s health by increasing equitable use of vaccines in lower-income countries”:

  1. The vaccine goal: accelerate equitable uptake and coverage of vaccines;
  2. The systems goal: increase effectiveness and efficiency of immunisation delivery as an integrated part of strengthened health systems;
  3. The sustainability goal: improve sustainability of national immunisation programmes;
  4. The market shaping goal: shape markets for vaccines and other immunisation products.


The strategic framework includes eight principles, intended to define the Vaccine Alliance’s characteristics, its business model and its aspirations: country-led, community-owned, globally engaged, catalytic and sustainable, integrated, innovative, collaborative and accountable.

Strategic enablers

The framework also includes four “strategic enablers”. These are critical elements that the Vaccine Alliance, including countries, need to put in place to successfully achieve the four strategic goals.

The strategic enablers are: in-country leadership, management & coordination; advocacy; resource mobilisation and monitoring & evaluation.

>18 million

Since its creation in 2013, the Gavi-supported global oral cholera vaccine stockpile has distributed over 18 million doses to 18 countries. In 2017, nine countries – Bangladesh, Cameroon, Haiti, Malawi, Mozambique, Nigeria, Sierra Leone, Somalia and South Sudan – accessed the stockpile.


More facts...

close icon

modal window here